Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Advanced Chemotherapy Technologies, a US-based cancer drug delivery spinout of University of North Carolina at Chapel Hill, closed a $5.5m series A round yesterday led by venture capital firm Khosla Ventures. The funding will be used to drive initial clinical development of its technology, targeting certain forms of pancreatic cancer. SurfactGreen, a France-based surfactant chemical…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.